يعرض 1 - 20 نتائج من 136 نتيجة بحث عن '"Turmelle, Yumirle P."', وقت الاستعلام: 1.09s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المصدر: Journal of Pediatric Gastroenterology and Nutrition. 59(6)

    وصف الملف: application/pdf

  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المصدر: JAMA. 311(17)

    وصف الملف: application/pdf

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المساهمون: Pediatrics, School of Medicine

    المصدر: PMC

    مصطلحات موضوعية: Hepatitis, Jaundice, Liver, Neonatal, Transient

    وصف الملف: application/pdf

    Relation: Journal of Pediatric Gastroenterology and Nutrition; Hertel PM, Hawthorne K, Kim S, et al. Presentation and Outcomes of Infants With Idiopathic Cholestasis: A Multicenter Prospective Study. J Pediatr Gastroenterol Nutr. 2021;73(4):478-484. doi:10.1097/MPG.0000000000003248; https://hdl.handle.net/1805/31816

  14. 14
    Academic Journal

    المساهمون: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, University of Pennsylvania, National Niemann Pick Disease Foundation, National Center for Advancing Translational Sciences, Mallinckrodt Pharmaceuticals

    المصدر: Molecular Genetics and Metabolism Reports ; volume 28, page 100772 ; ISSN 2214-4269

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    مصطلحات موضوعية: Internal Medicine and Specialties, Health Sciences

    وصف الملف: application/pdf

    Relation: Feng, Sandy; Bucuvalas, John C.; Mazariegos, George V.; Magee, John C.; Sanchez‐fueyo, Alberto; Spain, Katharine M.; Lesniak, Andrew; Kanaparthi, Sai; Perito, Emily; Venkat, Veena L.; Burrell, Bryna E.; Alonso, Estella M.; Bridges, Nancy D.; Doo, Edward; Gupta, Nitika A.; Himes, Ryan W.; Ikle, David; Jackson, Annette M.; Lobritto, Steven J.; Jose Lozano, Juan; Martinez, Mercedes; Ng, Vicky L.; Rand, Elizabeth B.; Sherker, Averell H.; Sundaram, Shikha S.; Turmelle, Yumirle P.; Wood‐trageser, Michele; Demetris, Anthony J. (2021). "Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management." Hepatology (5): 1985-2004.; https://hdl.handle.net/2027.42/167499; Hepatology; Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, Split Research Group. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007; 7: 2165 - 2171.; Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86: 1837 - 1843.; Scheenstra R, Peeters PM, Verkade HJ, Gouw AS. Graft fibrosis after pediatric liver transplantation: ten years of follow- up. Hepatology 2009; 49: 880 - 886.; Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, et al. Donor- specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation. Transplantation 2015; 99: 1416 - 1422.; Aberg F, Isoniemi H, Pukkala E, Jalanko H, Rasmussen A, Storm HH, et al. Cancer after liver transplantation in children and young adults: a population- based study from 4 nordic countries. Liver Transpl 2018; 24: 1252 - 1259.; Martinelli J, Habes D, Majed L, Guettier C, Gonzales E, Linglart A, et al. Long- term outcome of liver transplantation in childhood: a study of 20- year survivors. Am J Transplant 2018; 18: 1680 - 1689.; Memaran N, Borchert- Morlins B, Schmidt BMW, Sugianto RI, Wilke H, Blote R, et al. High burden of subclinical cardiovascular target organ damage after pediatric liver transplantation. Liver Transpl 2019; 25: 752 - 762.; Ruebner RL, Reese PP, Denburg MR, Abt PL, Furth SL. End- stage kidney disease after pediatric nonrenal solid organ transplantation. Pediatrics 2013; 132: e1319 - e1326.; Feng S, Bucuvalas J. Tolerance after liver transplantation: where are we? Liver Transpl 2017; 23: 1601 - 1614.; Levitsky J, Feng S. Tolerance in clinical liver transplantation. Hum Immunol 2018; 79: 283 - 287.; Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, et al. Late acute rejection after liver transplantation impacts patient survival. Clin Transplant 2008; 22: 316 - 323.; Thurairajah PH, Carbone M, Bridgestock H, Thomas P, Hebbar S, Gunson BK, et al. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era. Transplantation 2013; 95: 955 - 959.; Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion RM, et al. Acute rejection increases risk of graft failure and death in recent liver transplant recipients. Clin Gastroenterol Hepatol 2017; 15: 584 - 593.e582.; Jadlowiec CC, Morgan PE, Nehra AK, Hathcock MA, Kremers WK, Heimbach JK, et al. Not all cellular rejections are the same: differences in early and late hepatic allograft rejection. Liver Transpl 2019; 25: 425 - 435.; Benitez C, Londono MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013; 58: 1824 - 1835.; Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307: 283 - 293.; Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, et al. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Am J Transplant 2019; 19: 1397 - 1409.; Liver Transpl Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transplant 2012; 18: 1154 - 1170.; Bonaccorsi- Riani E, Pennycuick A, Londono MC, Lozano JJ, Benitez C, Sawitzki B, et al. Molecular characterization of acute cellular rejection occurring during intentional immunosuppression withdrawal in liver transplantation. Am J Transplant 2016; 16: 484 - 496.; Bohne F, Martinez- Llordella M, Lozano JJ, Miquel R, Benitez C, Londono MC, et al. Intra- graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368 - 382.; Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca- Quinones J, et al. Novel histologic scoring system for long- term allograft fibrosis after liver transplantation in children. Am J Transplant 2012; 12: 2986 - 2996.; Demetris AJ, Bellamy C, Hubscher SG, O’Leary J, Randhawa PS, Feng S, et al. 2016 comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody- mediated rejection. Am J Transplant 2016; 16: 2816 - 2835.; Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr 2012; 160: 820 - 826.e823.; Wong YC, Tay SS, McCaughan GW, Bowen DG, Bertolino P. Immune outcomes in the liver: Is CD8 T cell fate determined by the environment? J Hepatol 2015; 63: 1005 - 1014.; Londono MC, Souza LN, Lozano JJ, Miquel R, Abraldes JG, Llovet LP, et al. Molecular profiling of subclinical inflammatory lesions in long- term surviving adult liver transplant recipients. J Hepatol 2018; 69: 626 - 634.; Campbell PM, Senior PA, Salam A, Labranche K, Bigam DL, Kneteman NM, et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007; 7: 2311 - 2317.; Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, et al. Adverse outcomes of tacrolimus withdrawal in immune- quiescent kidney transplant recipients. J Am Soc Nephrol 2015; 26: 3114 - 3122.; Jucaud V, Shaked A, DesMarais M, Sayre P, Feng S, Levitsky J, et al. Prevalence and impact of de novo donor- specific antibodies during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients. Hepatology 2019; 69: 1273 - 1286.; Wiebe C, Gibson IW, Blydt- Hansen TD, Pochinco D, Birk PE, Ho J, et al. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor- specific antibody. Am J Transplant 2015; 15: 2921 - 2930.; Hodges AM, Lyster H, McDermott A, Rice AJ, Smith JD, Rose ML, et al. Late antibody- mediated rejection after heart transplantation following the development of de novo donor- specific human leukocyte antigen antibody. Transplantation 2012; 93: 650 - 656.; Le Pavec J, Suberbielle C, Lamrani L, Feuillet S, Savale L, Dorfmuller P, et al. De- novo donor- specific anti- HLA antibodies 30 days after lung transplantation are associated with a worse outcome. J Heart Lung Transplant 2016; 35: 1067 - 1077.; Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, et al. Prevalence, course and impact of HLA donor- specific antibodies in liver transplantation in the first year. Am J Transplant 2012; 12: 1504 - 1510.; O’Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, et al. The role of donor- specific HLA alloantibodies in liver transplantation. Am J Transplant 2014; 14: 779 - 787.; Feng S, Demetris AJ, Spain KM, Kanaparthi S, Burrell BE, Ekong UD, et al. Five- year histological and serological follow- up of operationally tolerant pediatric liver transplant recipients enrolled in WISP- R. Hepatology 2017; 65: 647 - 660.; Del Bello A, Congy- Jolivet N, Danjoux M, Muscari F, Kamar N. Donor- specific antibodies and liver transplantation. Hum Immunol 2016; 77: 1063 - 1070.; Vandevoorde K, Ducreux S, Bosch A, Guillaud O, Hervieu V, Chambon- Augoyard C, et al. Prevalence, risk factors, and impact of donor- specific alloantibodies after adult liver transplantation. Liver Transpl 2018; 24: 1091 - 1100.; Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, et al. A pilot study of operational tolerance with a regulatory T cell- based cell therapy in living donor liver transplantation. Hepatology 2016; 64: 632 - 643.; Crispe IN. Immune tolerance in liver disease. Hepatology 2014; 60: 2109 - 2117.; Jackson AM, Kanaparthi S, Burrell BE, Lucas DP, Vega RM, Demetris AJ, et al. IgG4 donor- specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients. Am J Transplant 2020; 20: 513 - 524.; Levitsky J, Burrell BE, Kanaparthi S, Turka LA, Kurian S, Sanchez- Fueyo A, et al. Immunosuppression withdrawal in liver transplant recipients on sirolimus. Hepatology 2019 Nov 13. https://doi.org/10.1002/hep.31036. [Epub ahead of print]; Wong T, Nouri- Aria KT, Devlin J, Portmann B, Williams R. Tolerance and latent cellular rejection in long- term liver transplant recipients. Hepatology 1998; 28: 443 - 449.; Heymann F, Peusquens J, Ludwig- Portugall I, Kohlhepp M, Ergen C, Niemietz P, et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 2015; 62: 279 - 291.; Taubert R, Danger R, Londono MC, Christakoudi S, Martinez- Picola M, Rimola A, et al. Hepatic infiltrates in operational tolerant patients after liver transplantation show enrichment of regulatory T cells before proinflammatory genes are downregulated. Am J Transplant 2016; 16: 1285 - 1293.; Ekong UD, Melin- Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, et al. Graft histology characteristics in long- term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582 - 1587.; Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109 - 1117.; Feng S, Bucuvalas JC, Demetris AJ, Burrell BE, Spain KM, Kanaparthi S, et al. Evidence of chronic allograft injury in liver biopsies from long- term pediatric recipients of liver transplants. Gastroenterology 2018; 155: 1838 - 1851.e1837.; Guerra MR, Naini BV, Scapa JV, Reed EF, Busuttil RW, Cheng EY, et al. Obliterative portal venopathy: a histopathologic finding associated with chronic antibody- mediated rejection in pediatric liver allografts. Pediatr Transplant 2018; 22: e13124.; Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl 2008; 14: 946 - 955.; Miyagawa- Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, et al. Progressive graft fibrosis and donor- specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl 2012; 18: 1333 - 1342.

  18. 18
    Academic Journal

    المساهمون: Pediatrics, School of Medicine

    المصدر: PMC

    مصطلحات موضوعية: ATP8B1, ABCB11, ABCB4, Liver transplant, Cholestasis

    وصف الملف: application/pdf

    Relation: Journal of Pediatric Gastroenterology and Nutrition; Hertel PM, Bull LN, Thompson RJ, et al. Mutation Analysis and Disease Features at Presentation in a Multi-Center Cohort of Children With Monogenic Cholestasis. J Pediatr Gastroenterol Nutr. 2021;73(2):169-177. doi:10.1097/MPG.0000000000003153; https://hdl.handle.net/1805/42354

  19. 19
    Academic Journal
  20. 20